Emcure Pharmaceuticals debuts strongly in stock markets, hits ₹1,325 per share
Emcure Pharmaceuticals achieves a 31.45% IPO gain; Prashanth Tapse advises investors to hold for long-term growth
Emcure Pharmaceuticals achieves a 31.45% IPO gain; Prashanth Tapse advises investors to hold for long-term growth